Welcome to our dedicated page for Iqvia Hldgs SEC filings (Ticker: IQV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IQVIA Holdings Inc. (NYSE: IQV) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. IQVIA’s filings confirm that its common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on the New York Stock Exchange under the symbol IQV.
IQVIA uses Form 8-K to report material events such as quarterly financial results, amendments to its credit agreements and leadership or board changes. For example, the company has filed 8-K reports describing financial results for specific quarters, an amendment to its Fifth Amended and Restated Credit Agreement and the planned transition of its chief financial officer. Other 8-K filings cover the appointment of new directors and related governance matters.
For investors analyzing IQVIA, these filings help explain the company’s financial condition, capital structure and key corporate developments. They also provide context for IQVIA’s role as a global provider of clinical research services, commercial insights and healthcare intelligence, including how it finances its operations and manages governance and leadership transitions.
On Stock Titan, SEC filings for IQVIA are updated as new documents are posted to the SEC’s EDGAR system. AI-powered summaries help interpret lengthy filings by highlighting important sections, such as descriptions of material agreements, financial updates or changes in executive roles. Users can review 8-Ks for event-driven information and refer to other filing types, such as annual and quarterly reports when available, to gain a more complete view of IQVIA’s business and risks.
IQVIA Holdings executive Eric Sherbet reported equity transactions tied to performance-based awards. On February 8, 2026, he acquired 6,806 shares of common stock at $0, delivered upon the achievement of performance criteria for restricted stock units granted on February 13, 2023.
On the same date, 1,915 shares were disposed of at $187.49 per share, consistent with a share withholding transaction typically used to cover tax obligations. After these transactions, Sherbet directly held 25,999 shares of IQVIA common stock.
IQVIA Holdings Inc. officer W. Richard Staub reported equity transactions in company common stock. On February 8, 2026, he acquired 2,722 shares of common stock at $0 per share, increasing his directly held position to 19,618 shares.
The acquired shares were delivered upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023, after the company’s Leadership Development and Compensation Committee determined on February 8, 2026 that the conditions had been satisfied.
On the same date, 806 shares of common stock were disposed of at a price of $187.49 per share, leaving Staub with 18,812 shares of IQVIA common stock held directly following the reported transactions.
IQVIA Holdings reported that officer Keriann Cherofsky received 1,087 shares of common stock on February 8, 2026 at $0 per share. These shares were earned after performance conditions tied to performance-based restricted stock units granted on February 13, 2023 were certified as satisfied by the company’s Leadership Development and Compensation Committee.
On the same date, 415 shares of common stock were disposed of at $187.49 per share, leaving Cherofsky with 3,547 shares of IQVIA common stock held directly after the reported transactions.
IQVIA Holdings executive vice president and chief financial officer Ronald E. Bruehlman reported equity transactions in company common stock on February 8, 2026. He acquired 16,335 shares at $0 per share upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023, after the company’s Leadership Development and Compensation Committee determined those conditions were satisfied.
On the same date, he disposed of 6,801 shares of common stock in a transaction coded “F” at $187.49 per share. Following these transactions, Bruehlman directly owned 44,103 shares of IQVIA common stock and indirectly owned an additional 11,893 shares through the Ronald E. Bruehlman Revocable Trust.
IQVIA Holdings executive James G. Berkshire reported equity compensation activity. On February 8, 2026, he acquired 2,722 shares of common stock at $0.00 per share upon achievement of performance criteria tied to performance-based restricted stock units granted on February 13, 2023.
On the same date, 1,280 shares of common stock were disposed of at $187.49 per share, leaving him with 8,177 shares of IQVIA common stock held directly. The award’s performance conditions were confirmed as satisfied by the company’s Leadership Development and Compensation Committee on February 8, 2026.
IQVIA Holdings Inc. Chairman, Chief Executive Officer & President Ari Bousbib reported equity-related transactions in the company’s common stock on February 8, 2026. He acquired 57,177 shares at $0 when performance conditions on previously granted performance-based restricted stock units were certified as achieved by the Leadership Development and Compensation Committee. On the same day, 28,399 shares were disposed of at $187.49 in a transaction coded “F,” indicating shares were withheld to cover taxes. Following these transactions, he directly owned 835,941 common shares and indirectly held 543,302 shares through the Orohena Trust.
IQVIA Holdings Inc. filed a current report to let investors know it released its financial results for the fourth quarter and full year ended December 31, 2025. The company announced these results through a press release dated February 5, 2026.
The press release is available on IQVIA’s website and is furnished as Exhibit 99.1 to this report. The company notes that this information is being furnished, not filed, meaning it is not subject to certain liability provisions of the Securities Exchange Act and is not automatically incorporated into other securities filings.
IQVIA Holdings Inc. senior vice president of FP&A Michael J. Fedock reported a disposition of common stock. On 01/28/2026, he disposed of 381 shares of IQVIA common stock at a reported price of $239.76 per share, leaving him with 5,391 shares held directly after the transaction.
IQVIA Holdings executive Bernd Haas, EVP of AI and Technology Solutions, reported his initial holdings of the company’s equity. He directly beneficially owns 16,589 shares of IQVIA common stock, which include restricted stock units that are scheduled to vest on February 13, 2026 and January 28, 2028. He also holds multiple stock appreciation rights over IQVIA common stock, with grants covering share amounts such as 2,781, 4,032 and 8,778, and exercise prices ranging from $95.23 to $250.43, expiring between 2028 and 2035. Several of these awards have portions already vested, with the remaining parts set to vest in annual installments beginning in 2026.
IQVIA Holdings executive Alistair Grenfell, President, Commercial Solutions, reported his initial ownership in the company as of 12/31/2025. He beneficially owns 17,874 shares of common stock held directly. In addition, he holds several stock appreciation rights (SARs) over IQVIA common stock, including 8,193 shares at $250.43 per share exercisable until 02/10/2032 and 10,300 shares at $232.11 per share expiring on 02/13/2033, with portions already vested and the remainder scheduled to vest beginning in 2026. Further SAR grants cover 17,266 shares at $214.34 expiring 02/07/2034 and 28,091 shares at $203.43 expiring 01/28/2035, with vesting in annual installments starting in 2026.